HLB has secured FDA for Lyrfigtu (lirafugratinib), an fibroblast growth factor receptor 2 (FGFR2)-targeted cancer drug for ...

For decades, radiologists have injected gadolinium-based contrast agents directly into patients’ joints for magnetic ...

Doctors have long known that smoking raises the risk of macular degeneration, an eye disease that slowly erodes central vision. What they could hardly untangle is why. Is it the nicotine in cigarettes ...

Calls are growing for an overhaul of Korea’s disability assessment criteria for dwarfism, which critics say have direct ...

Sepsis, a condition in which an abnormal, excessive immune response to infection damages major organs, is a medical emergency ...

Nineteen recipients of government public health scholarships have failed to complete their mandatory service without ...

A hospital has formally apologized to the family of a nurse who had reported workplace bullying before her death and agreed ...

Compass Therapeutics said Monday that U.S. regulators have recommended it run a trial showing a survival benefit before ...

Onconic Therapeutics’ Chinese partner has dosed the first patient in a phase 3 trial of an injectable formulation of ...

Korea’s spending on healthcare services and medical goods provided directly to individual patients surpassed 200 trillion won ($147 billion) for the first time in 2024, while households paid 67.2 tril ...

Daewoong Pharmaceutical has launched its gastroesophageal reflux disease (GERD) treatment Fexuclue (fexuprazan) in Indonesia, seeking to build a prescription base in Southeast Asia’s largest economy a ...

Korea risks losing ground as a global clinical trial hub as China rapidly expands its presence and Japan reforms its regulatory environment, prompting experts to call for more flexible policies to kee ...